Mechanisms of trichostatin A inhibiting AGS proliferation and identification of lysine-acetylated proteins

World Journal of Gastroenterology

Volumn 19, Issue 21, 2013, Pages 3226-3240

  Wang, Yu Gang ^a   Wang, Na ^a   Li, Guang Ming ^b   Fang, Wen Li ^a   Wei, Jue ^a   Ma, Jia Li ^a   Wang, Ting ^a   Shi, Min ^a  

^a Shanghai Changning Central Hospital   (China)

^b XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acetylation modification; ATP5O; Gastric cancer; Mass spectrometry; PKM2; Trichostatin A

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; CYCLIN D1; CYCLIN DEPENDENT KINASE ACTIVATING KINASE; LYSINE; P21 ACTIVATED KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TRICHOSTATIN A;

ACETYLATION; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; ELECTROPHORESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING;

EID: 84878602376     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i21.3226     Document Type: Article

References (36)

1. Krejs GJ. Gastric cancer: epidemiology and risk factors. Dig Dis 2010; 28: 600-603 [PMID: 21088409 DOI: 10.1159/000320277]
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
3. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006; 12: 17-20 [PMID: 16440411]
4. Dhordain P, Lin RJ, Quief S, Lantoine D, Kerckaert JP, Evans RM, Albagli O. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res 1998; 26: 4645-4651 [PMID: 9753732]
5. Balaguer TM, Gómez-Martínez A, García-Morales P, Lacueva J, Calpena R, Reverte LR, Riquelme NL, Martinez-Lacaci I, Ferragut JA, Saceda M. Dual regulation of P-glycoprotein expression by trichostatin A in cancer cell lines. BMC Mol Biol 2012; 13: 25 [PMID: 22846052 DOI: 10.1186/1471-2199-13-25]
6. Zhang QC, Jiang SJ, Zhang S, Ma XB. Histone deacetylase inhibitor trichostatin A enhances anti-tumor effects of docetaxel or erlotinib in A549 cell line. Asian Pac J Cancer Prev 2012; 13: 3471-3476 [PMID: 22994780]
7. Su L, Xu G, Shen J, Tuo Y, Zhang X, Jia S, Chen Z, Su X. Anticancer bioactive peptide suppresses human gastric cancer growth through modulation of apoptosis and the cell cycle. Oncol Rep 2010; 23: 3-9 [PMID: 19956858]
8. Guan KL, Yu W, Lin Y, Xiong Y, Zhao S. Generation of acetyllysine antibodies and affinity enrichment of acetylated peptides. Nat Protoc 2010; 5: 1583-1595 [PMID: 21085124 DOI: 10.1038/nprot.2010.117]
9. Chen Y, Kwon SW, Kim SC, Zhao Y. Integrated approach for manual evaluation of peptides identified by searching protein sequence databases with tandem mass spectra. J Proteome Res 2005; 4: 998-1005 [PMID: 15952748 DOI: 10.1021/pr049754t]
10. Vàdineanu A, Berden JA, Slater EC. Proteins required for the binding of mitrochondrial ATPase to the mitochondrial inner membrane. Biochim Biophys Acta 1976; 449: 468-479 [PMID: 136985]
11. Willingham MC, Rutherford AV, Cheng SY. Immunohistochemical localization of a thyroid hormone-binding protein (p55) in human tissues. J Histochem Cytochem 1987; 35: 1043-1046 [PMID: 3305699]
12. Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011; 17: 330-339 [PMID: 21386836 DOI: 10.1038/nm.2305]
13. Cortez CC, Jones PA. Chromatin, cancer and drug therapies. Mutat Res 2008; 647: 44-51 [PMID: 18691602 DOI: 10.1016/j.mrfmmm.2008.07.006]
14. Ma P, Pan H, Montgomery RL, Olson EN, Schultz RM. Compensatory functions of histone deacetylase 1 (HDAC1) and HDAC2 regulate transcription and apoptosis during mouse oocyte development. Proc Natl Acad Sci USA 2012; 109: E481-E489 [PMID: 22223663 DOI: 10.1073/pnas.1118403109]
15. Marks PA, Richon VM, Breslow R, Rifkind RA. Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol 2001; 13: 477-483 [PMID: 11673688]
16. Takai N, Ueda T, Nishida M, Nasu K, Narahara H. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells. Int J Mol Med 2006; 17: 323-329 [PMID: 16391833]
17. Chang J, Varghese DS, Gillam MC, Peyton M, Modi B, Schiltz RL, Girard L, Martinez ED. Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide. Br J Cancer 2012; 106: 116-125 [PMID: 22158273 DOI: 10.1038/ bjc.2011.532]
18. Agudelo M, Gandhi N, Saiyed Z, Pichili V, Thangavel S, Khatavkar P, Yndart-Arias A, Nair M. Effects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA). Alcohol Clin Exp Res 2011; 35: 1550-1556 [PMID: 21447001 DOI: 10.1111/j.1530-0277.2011.01492.x]
19. Meng J, Zhang HH, Zhou CX, Li C, Zhang F, Mei QB. The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53- dependent and -independent pathways. Oncol Rep 2012; 28: 384-388 [PMID: 22552631 DOI: 10.3892/or.2012.1793]
20. Suzuki T, Yokozaki H, Kuniyasu H, Hayashi K, Naka K, Ono S, Ishikawa T, Tahara E, Yasui W. Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis- related molecules in human gastric and oral carcinoma cell lines. Int J Cancer 2000; 88: 992-997 [PMID: 11093826]
21. Zou XM, Li YL, Wang H, Cui W, Li XL, Fu SB, Jiang HC. Gastric cancer cell lines induced by trichostatin A. World J Gastroenterol 2008; 14: 4810-4815 [PMID: 18720545]
22. Anh TD, Ahn MY, Kim SA, Yoon JH, Ahn SG. The histone deacetylase inhibitor, Trichostatin A, induces G2/M phase arrest and apoptosis in YD-10B oral squamous carcinoma cells. Oncol Rep 2012; 27: 455-460 [PMID: 21993600 DOI: 10.3892/or.2011.1496]
23. Chen CS, Weng SC, Tseng PH, Lin HP, Chen CS. Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes. J Biol Chem 2005; 280: 38879-38887 [PMID: 16186112]
24. Bártová E, Pacherník J, Harnicarová A, Kovarík A, Kovaríková M, Hofmanová J, Skalníková M, Kozubek M, Kozubek S. Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases. J Cell Sci 2005; 118: 5035-5046 [PMID: 16254244]
25. Fortson WS, Kayarthodi S, Fujimura Y, Xu H, Matthews R, Grizzle WE, Rao VN, Bhat GK, Reddy ES. Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells. Int J Oncol 2011; 39: 111-119 [PMID: 21519790 DOI: 10.3892/ijo.2011.1014]
26. Bajbouj K, Mawrin C, Hartig R, Schulze-Luehrmann J, Wilisch-Neumann A, Roessner A, Schneider-Stock R. P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells. J Neurooncol 2012; 107: 503-516 [PMID: 22270849 DOI: 10.1007/s11060-011-0791-2]
27. Alao JP, Stavropoulou AV, Lam EW, Coombes RC, Vigushin DM. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells. Mol Cancer 2006; 5: 8 [PMID: 16504004]
28. Kim IA, Shin JH, Kim IH, Kim JH, Kim JS, Wu HG, Chie EK, Ha SW, Park CI, Kao GD. Histone deacetylase inhibitormediated radiosensitization of human cancer cells: class differences and the potential influence of p53. Clin Cancer Res 2006; 12: 940-949 [PMID: 16467109]
29. Chan ST, Yang NC, Huang CS, Liao JW, Yeh SL. Quercetin enhances the antitumor activity of trichostatin A through upregulation of p53 protein expression in vitro and in vivo. PLoS One 2013; 8: e54255 [PMID: 23342112]
30. Juan LJ, Shia WJ, Chen MH, Yang WM, Seto E, Lin YS, Wu CW. Histone deacetylases specifically down-regulate p53-dependent gene activation. J Biol Chem 2000; 275: 20436-20443 [PMID: 10777477]
31. Gui CY, Ngo L, Xu WS, Richon VM, Marks PA. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc Natl Acad Sci USA 2004; 101: 1241-1246 [PMID: 14734806]
32. Marks PA, Breslow R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol 2007; 25: 84-90 [PMID: 17211407]
33. Rizzardini M, Lupi M, Mangolini A, Babetto E, Ubezio P, Cantoni L. Neurodegeneration induced by complex I inhibition in a cellular model of familial amyotrophic lateral sclerosis. Brain Res Bull 2006; 69: 465-474 [PMID: 16624679]
34. Gupta V, Bamezai RN. Human pyruvate kinase M2: a multifunctional protein. Protein Sci 2010; 19: 2031-2044 [PMID: 20857498 DOI: 10.1002/pro.505]
35. Mazurek S. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol 2011; 43: 969-980 [PMID: 20156581 DOI: 10.1016/ j.biocel.2010.02.005]
36. Lv L, Li D, Zhao D, Lin R, Chu Y, Zhang H, Zha Z, Liu Y, Li Z, Xu Y, Wang G, Huang Y, Xiong Y, Guan KL, Lei QY. Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Mol Cell 2011; 42: 719-730 [PMID: 21700219 DOI: 10.1016/j.molcel.2011.04.025]